Advertisement

Chinese Journal of Integrative Medicine

, Volume 24, Issue 1, pp 3–5 | Cite as

Contrast-induced nephropathy—time for Western medicine and Chinese medicine to team up

  • Svante Norgren
  • Xue-zhong Gong
Feature Article
  • 67 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lewington A, MacTier R, Hoefield R, Sutton A, Smith D, Downes M. Prevention of contrast induced acute kidney injury (CI-AKI) in adult patients. On behalf of the Renal Association, British Cardiovascular Intervention Society and The Royal College of Radiologists, 2013. Available at:http://www.renal.org/docs/default-source/guidelines-resources/ joint-guidelines/Prevention_of_Contrast_Induced_Acute_Kidney_Injury_CI-AKI_In_Adult_Patients.pdf.Google Scholar
  2. 2.
    Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl 2012;2:69–88.Google Scholar
  3. 3.
    Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989;36:730–740.CrossRefPubMedGoogle Scholar
  4. 4.
    Gong X, Duan Y, Zheng J, Wang Y, Wang G, Norgren S, et al. Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats. Oxid Med Cell Longev 2016;2016:8715185.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Efferth T, Li PC, Konkimalla VB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007;13:353–361.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhao K, Li Y, Zhang H. Role of Dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. J Tradit Chin Med 2013;33:283–286.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhao K, Lin Y, Li Y, Gao S. Efficay of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Int J Clin Exp Med 2014;7:5758–5764.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res 2000;14:647–649.CrossRefPubMedGoogle Scholar
  9. 9.
    Huang J, Yuan M, Ma J, Liu R, Dong Z, Zhao G, et al. Protective effects of salvianolate on contrast-induced nephropathy after primary percutaneous coronary intervention: a prospective multicenter randomized controlled trial. Cardiology 2017;138:169–178.CrossRefPubMedGoogle Scholar
  10. 10.
    Ozkan G, Ulusoy S, Orem A, Ersoz S, Alkanat M, Yucesan FB, et al. Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy. Kidney Blood Press Res 2012;35:445–453.CrossRefPubMedGoogle Scholar
  11. 11.
    Gong X, Wang Q, Tang X, Wang Y, Fu D, Lu H, et al. Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. Am J Nephrol 2013;37:199–207.CrossRefPubMedGoogle Scholar
  12. 12.
    Chu SC, Hu LH, Wang XL, Sun SQ, Zhang T, Sun Z, et al. Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis. Renal Failure 2016;38:1717–1725.CrossRefPubMedGoogle Scholar
  13. 13.
    Ulusoy S, Ozkan G, Mungan S, Yucesan FB. GSPE is superior to NAC in the prevention of contrast-induced nephropathy: might this superiority be related to caspase 1 and calpain 1? Life Sci 2014;103:101–110.CrossRefPubMedGoogle Scholar
  14. 14.
    Kitano H. Computational systems biology. Nature 2002;420:206–210.CrossRefPubMedGoogle Scholar
  15. 15.
    Jiang W. Therapeutic wisdom in tradtional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005;26:558–563.CrossRefPubMedGoogle Scholar
  16. 16.
    Konkimalla VB, Efferth T. Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol 2008;116:207–210.CrossRefPubMedGoogle Scholar
  17. 17.
    Wang M, Xie T, Chang Z, Wang L, Xie X, Kou Y, et al. A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects. PLoS ONE 2015;10(12): e0143625.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Children’s and Women’s Health ThemeKarolinska University HospitalStockholmSweden
  2. 2.Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese MedicineShanghai University of Traditional Chinese MedicineShanghaiChina

Personalised recommendations